REVIEW ARTICLE |
|
Year : 2022 | Volume
: 20
| Issue : 2 | Page : 89-94 |
|
Polycystic ovary syndrome: Current perspectives and recent advances
AY Nirupama1, Jennifer Britto John2, D Vinoth Gnana Chellaiyan3
1 Department of Public Health Research, Indian Institute of Public Health, Hyderabad, Telangana, India 2 Department of Obstetrics and Gynecology, Chettinad Hospital and Research Institute, Chettinad Academy of Research and Education, Chennai, Tamil Nadu, India 3 Department of Community Medicine, Chettinad Academy of Research and Education, Chennai, Tamil Nadu, India
Correspondence Address:
Dr. D Vinoth Gnana Chellaiyan Department of Community Medicine, Chettinad Academy of Research and Education, Kelambakkam, Chennai - 603 103, Tamil Nadu India
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/cmi.cmi_2_22
|
|
Excess ovarian activity, chronic anovulation, and androgen excess are the common traits of polycystic ovary syndrome (PCOS). Several advances have been made in understanding the pathophysiology in the process of finding quicker and more effective management measures. Androgen excess in PCOS was found to correlate with markedly elevated luteinizing hormone pulsatility. Impaired insulin response is also attributed to PCOS. Regimen with 3 mg drospirenone + 20 μg ethinyl estradiol combination is beneficial for hormonal imbalance and lipid profile while having a substantial safety profile. Clinical evidence has demonstrated that a 40:1 combination of Myo-inositol and D-chiro-inositol restores ovulation in PCOS women. For women with clomiphene citrate-resistant PCOS, laparoscopic ovarian drilling has proved to be a safe and effective surgical alternative. PCOS is also an indication of bariatric surgery. To conclude, constitutional management by a multidisciplinary team may be helpful for women with PCOS. Lifestyle interventions are best advised and, in so doing, decrease body adiposity and recuperate their metabolic and reproductive health.
|
|
|
|
[FULL TEXT] [PDF]* |
|
 |
|